Ninčević, V., Omanović Kolarić, T., Roguljić, H., Kizivat, T., Smolić, M., & Bilić Ćurčić, I. (2019). Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes. Int J Mol Sci.
Chicago Style citaatNinčević, Vjera, Tea Omanović Kolarić, Hrvoje Roguljić, Tomislav Kizivat, Martina Smolić, en Ines Bilić Ćurčić. "Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes." Int J Mol Sci 2019.
MLA citatieNinčević, Vjera, et al. "Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes." Int J Mol Sci 2019.